The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer
Clinical trial NCT05438797 · UNKNOWN
Trial details
- NCT number
- NCT05438797
- Sponsor
- Sizhen Wang
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-02
- Primary completion
- 2024-04-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.